EUVIMEDEUVIMED entdecken
Open Access

Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity

Masuho Saburi, Kuniaki Maehara, Takumi Nishikawa, Takata Hiroyuki, Masanori Sakata, Kazuhiro Kohno, Yuko Ogata, Takami Haruyama, Eiichi Ohtsuka

Cureus · 06.05.2026

DOI: 10.7759/cureus.108385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 06.05.2026. Verfasst von Masuho Saburi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oita Prefectural Hospital, Oita, JPN. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

bosutinibchronic myeloid leukemiahepatic toxicityreal-world studytreatment discontinuation

Autor:innen und Institutionen

  • Department of Hematology, Oita Prefectural Hospital, Oita, JPN.
  • Hematology, Oita Kouseiren Tsurumi Hospital, Beppu, JPN.
  • Hematology, National Hospital Organization Beppu Medical Center, Beppu, JPN.
  • Hematology, Japan Community Health Care Organization (JCHO) Nankai Medical Center, Saiki, JPN.

Zitieren

APA

Saburi, M., Maehara, K., Nishikawa, T., Hiroyuki, T., Sakata, M., Kohno, K., Ogata, Y., Haruyama, T., & Ohtsuka, E. (2026). Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity. Cureus. https://doi.org/10.7759/cureus.108385

Vancouver

Saburi M, Maehara K, Nishikawa T, Hiroyuki T, Sakata M, Kohno K, et al. Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity. Cureus. 2026. doi:10.7759/cureus.108385

BibTeX
@article{Saburi2026,
  author = {Saburi, Masuho and Maehara, Kuniaki and Nishikawa, Takumi and Hiroyuki, Takata and Sakata, Masanori and Kohno, Kazuhiro and Ogata, Yuko and Haruyama, Takami and Ohtsuka, Eiichi},
  title = {Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.108385}
}
Kostenlos starten →